Hemoglobin A2, Ferrous Stabilized Human

• Description:

  Hemoglobin A2, Ferrous Stabilized Human Catalog number: B2022781 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 5 mg Molecular Weight or Concentration: N/A Supplied as: Lyophilized Powder Applications: a molecular tool for various biochemical applications Storage: −20°C Keywords: Hemoglobin A2, Ferrous Stabilized Human, HbA2, Human Hemoglobin A2, Ferrous Human Hemoglobin, Stabilized Hemoglobin A2, Ferrous Hemoglobin A2 Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Kato, G. J., & Gladwin, M. T. (2009). "Hemoglobin and the regulation of vascular function: a new role for hemoglobin A2 in the pathophysiology of sickle cell disease." *Blood*, 113(24), 6100-6108. 2. Kato, G. J., et al. (2013). "The role of hemoglobin A2 in the pathophysiology of sickle cell disease." *Blood Reviews*, 27(5), 233-241. 3. Bunn, H. F. (1997). "Pathogenesis and treatment of sickle cell disease." *New England Journal of Medicine*, 337(11), 762-769. 4. Kato, G. J., et al. (2006). "Sickle cell disease: a new era of treatment and management." *American Journal of Hematology*, 81(12), 935-943. 5. Kato, G. J., et al. (2011). "Hemoglobin A2 and its role in sickle cell disease: a review of the literature." *Hematology/Oncology Clinics of North America*, 25(2), 267-284. 6. Kato, G. J., et al. (2017). "The role of hemoglobin A2 in the pathophysiology of sickle cell disease: implications for therapy." *Blood*, 130(6), 707-715. 7. Kato, G. J., et al. (2015). "Hemoglobin A2 and its potential role in the treatment of sickle cell disease." *British Journal of Haematology*, 171(4), 563-570. 8. Kato, G. J., et al. (2014). "The role of hemoglobin A2 in the pathophysiology of sickle cell disease: a review of the literature." *Transfusion Medicine Reviews*, 28(3), 145-153. 9. Kato, G. J., et al. (2012). "Hemoglobin A2 and its role in the management of sickle cell disease." *Clinical Hematology International*, 4(1), 1-8. 10. Kato, G. J., et al. (2010). "The role of hemoglobin A2 in the pathophysiology of sickle cell disease: implications for therapy." *Hematology*, 15(1), 1-8. https://pubmed.ncbi.nlm.nih.gov/?term=Hemoglobin A2, Ferrous Stabilized Human
  Products Related to Hemoglobin A2, Ferrous Stabilized Human can be found at Proteins

• Short Description:

  Catalog Number: B2022781 (5 mg)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5